Cart
sales@molnova.com
Justicidin C(Neojusticin B)
CAS No. 17803-12-2
Justicidin C(Neojusticin B)( —— )
Catalog No. M32676 CAS No. 17803-12-2
Justicidin C is an antiviral lignan. Justicidin C shows strong antiviral activity against vesicular stomatitis virus and low cytotoxicity against rabbit lung cells (RL-33) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 461 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameJusticidin C(Neojusticin B)
-
NoteResearch use only, not for human use.
-
Brief DescriptionJusticidin C is an antiviral lignan. Justicidin C shows strong antiviral activity against vesicular stomatitis virus and low cytotoxicity against rabbit lung cells (RL-33) .
-
DescriptionJusticidin C is an antiviral lignan. Justicidin C shows strong antiviral activity against vesicular stomatitis virus and low cytotoxicity against rabbit lung cells (RL-33).
-
In VitroJusticidin C inhibits vesicular stomatitis virus and rabbit lung cells (RL-33) with MIC values of 16 μg/mL and 63 μg/mL, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17803-12-2
-
Formula Weight394.4
-
Molecular FormulaC22H18O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Adipic acid
From an industrial perspective, it is the most important dicarboxylic acid, mainly as a precursor for the production of nylon.
-
O-Acetyl-L-serine hy...
O-Acetylserine (OASS) is an acylated amino acid derivative. It is an intermediate in the biosynthesis of the common amino acid cysteine in bacteria and plants. Its presence in humans arises from either microbial metabolism in the gut or through consumption of foods containing OASS.
-
Trastuzumab deruxtec...
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd).
